FDA DEVICE FACTS
Femoral Trochanteric Nail System – Neonail
Neoortho Produtos Ortopédicos S/A
FDA-sourced product information for medical-device development research. Use the official FDA sources at the end of this page when the original public document wording is needed.医療機器開発の調査用に、FDA の公開情報から取った製品情報を示しています。公開文書の原文が必要なときは、このページの最後にある FDA の公式な出典をご覧ください。
Indications for use
Device Name: Femoral Trochanteric Nail System – Neonail The Femoral Trochanteric Nail System – Neonail is indicated for the treatment of stable and unstable fractures as well as for stabilization of bones and correction of bone deformities in the intracapsular, trochanteric, subtrochanteric and shaft regions of the femur. The subject devic e Femoral Trochanteric Nail System – Neonail has the follo wing differences regarding the INDICATIONS FOR USE when compared with the predicate device cleared in K200869: The subject device is not indicated in cases including osteoporotic and osteopenic bone; The subject device does not include a “U-Blade Lag Screw ” to be indicated for rotationally unstable fractures. However, the subject device indications for use are totally included in the indications of the predicate device, that is, the subject indications are an identical subset of the predicate indications. The differences are related to the additional “U -Blade Lag Screw” present only in the predicate system. The subject device is not intended to cover the functions of the predicate additional “U -Blade Lag Screw”. Thus, the differences do not ra ise new concerns regarding the safety and effectiveness of the subject device.
Device description, AI/software, PCCP, evaluation and limitations are available with an account: seven days of full access after free registration, then with the paid plan.機器の説明、AI・ソフトウェア、PCCP、評価、制限事項は、アカウントでご覧いただけます。無料登録から 7 日間はすべて利用でき、その後は有料プランでご利用いただけます。
OFFICIAL FDA SOURCES
FDA Record and Public Document Status
Record and document link states are stored separately.FDA Record と公開文書のリンクの状態は、別々に記録しています。